Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer
Clinical trial NCT01423903 · COMPLETED
Trial details
- NCT number
- NCT01423903
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2013-04-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.